Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use

References

• Adkins, J. E., E. W. Boyer, and C. R. McCurdy. 2011. Mitragyna speciosa, A psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry 11:1165–1175.
   PubMed Web of Science ®Google Scholar
• Ahmad, K., and Z. Aziz. 2012. Mitragyna speciosa use in the northern states of Malaysia: A Cross-sectional study. Journal of Ethnopharmacology 141:446–450. doi:10.1016/j.jep.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Anwar, M., R. Law, and J. Schier. 2016. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers - United States, 2010-2015. Centers for Disease Control and Prevention 65 (29):748–49.
   Google Scholar
• Apryani, E., M. T. Hidayat, M. A. A. Moklas, S. Fakurazi, and N. F. Idayu. 2010. Effects of mitragynine from Mitragyna speciosa Korth leaves on working memory. Journal of Ethnopharmacology 129:357–60. doi:10.1016/j.jep.2010.03.036.
   PubMed Web of Science ®Google Scholar
• Assanangkornchai, S., A. Muekthong, N. Sam-Angsri, and U. Pattanasattayawong. 2007. The use of mitragynine species (“Krathom”), an addictive plant, in Thailand. Substance Use & Misuse 42:2145–57. doi:10.1080/10826080701205869.
   PubMed Web of Science ®Google Scholar
• Babu, K. M., C. R. McCurdy, and E. W. Boyer. 2008. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clinical Toxicology 46:146–52. doi:10.1080/15563650701241795.
   PubMed Web of Science ®Google Scholar
• Boyer, E. W., K. M. Babu, J. E. Adkins, C. R. McCurdy, and J. H. Halpern. 2008. Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa Korth). Addiction 103:1048–50. doi:10.1111/j.1360-0443.2008.02209.x.
   PubMed Web of Science ®Google Scholar
• Domingo, O., G. Roider, A. Stover, M. Graw, F. Musshoff, H. Sachs, and W. Bicker. 2017. Mitragynine concentrations in two fatalities. Forensic Science International 271:e1–7. doi:10.1016/j.forsciint.2016.12.020.
   PubMed Web of Science ®Google Scholar
• Griffin, O. H., J. A. Daniels, and E. A. Gardner. 2016. Do you get what you paid for? An examination of products advertised as Kratom. Journal of Psychoactive Drugs 48 (5):330–335.
   PubMed Web of Science ®Google Scholar
• Griffin, O. H., and M. E. Webb. 2017. The scheduling of Kratom and selective use of data. Journal of Psychoactive Drugs 50 (5):1–7.
   Google Scholar
• Grundmann, O. 2017. Patterns of Kratom use and health impact in the US-Results from an online survey. Drug and Alcohol Dependence 176:63–70. doi:10.1016/j.drugalcdep.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Hassan, Z., M. Muzaimi, V. Navaratnam, N. H. M. Yusoff, F. W. Suhaimi, R. Vadivelu, B. K. Vicknasingam, D. Amato, S. V. Hörsten, N. I. W. Ismail, et al. 2013. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience & Biobehavioral Reviews 37:138–51. doi:10.1016/j.neubiorev.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Hazim, A. I., M. Mustapha, and S. M. Mansor. 2011. The Effects on motor behaviour and short-term memory tasks in mice following an acute administration of Mitragyna speciosa alkaloid extract and mitragynine. Journal of Medicinal Plants Research 5 (24):5810–17.
   Google Scholar
• Hemby, S. E., S. McIntosh, F. Leon, S. J. Cutler, and C. R. McCurdy. 2018. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine. Addiction Biology. doi:10.1111/adb.12639.
   PubMed Web of Science ®Google Scholar
• Henningfield, J. E., R. V. Fant, and D. W. Wang. 2018. The abuse potential of kratom according the 8 factors of the controlled substances act: Implications for regulation and research. Psychopharmacoloy 235:573–89. doi:10.1007/s00213-017-4813-4.
   PubMed Web of Science ®Google Scholar
• Ilmie, M. U., S. M. Mansor, and J. M. Abdullah. 2015. Behavioural and electrophysiological evidence of impaired learning and memory in male sprague dawley rats following subchronic exposure to standardized methanolic extract of Mitragyna Speciosa Korth. Malaysian Journal of Medical Sciences special issue:45–51.
   PubMed Web of Science ®Google Scholar
• Ismail, N. I. W., N. Jayabalan, S. M. Mansor, C. P. Müller, and M. Muzaimi. 2016. Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice. Addiction Biology. in press. doi:10.1111/adb.12385.
   PubMed Web of Science ®Google Scholar
• Kamboj, S. K., A. Tookman, L. Jones, and H. V. Curran. 2005. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117:388–95. doi:10.1016/j.pain.2005.06.022.
   PubMed Web of Science ®Google Scholar
• Kronstrand, R., M. Roman, G. Thelander, and A. Eriksson. 2011. Unintentional fatal intoxications with mitragynine and o-desmethyltramadol from the herbal blend krypton. Journal of Analytical Toxicology 35:242–247.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., M. M. Gassaway, A. Kapoor, A. Varadi, S. Majumdar, M. Filizola, J. A. Javitch, and D. Sames. 2016. Synthetic and receptor signaling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. Journal Of The American Chemical Society 138 (21):6754–6764.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., and O. Grundmann. 2017. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 134:108–120.
   PubMed Web of Science ®Google Scholar
• Lydecker, A. G., A. Sharma, C. R. McCurdy, B. A. Avery, K. M. Babu, and E. W. Boyer. 2016. Suspected adulteration of commercial kratom products with 7-hydroxymitragynine. Journal Of Medical Toxicology 21:341–349.
   Web of Science ®Google Scholar
• Matsumoto, K., Y. Hatori, T. Murayama, K. Tashima, S. Wongseripipatana, K. Misawa, M. Kitajima, H. Takayama, and S. Horie. 2006. Involvement of µ-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa. European Journal of Pharmacology 549:63–70. doi:10.1016/j.ejphar.2006.08.013.
   PubMed Web of Science ®Google Scholar
• Ornstein, T. J., J. L. Iddon, A. M. Baldacchino, B. J. Sahakian, M. London, B. J. Everitt, and T. W. Robbins. 2000. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23:113–26. doi:10.1016/S0893-133X(00)00097-X.
   PubMed Web of Science ®Google Scholar
• Pinney Associates 2016. Assessment of Kratom under the CSA eight factors and scheduling recommendation. https://purkratom.com/media/wysiwyg/PinneyAssociates8factorAnalysis.pdf.
   Google Scholar
• Prozialeck, W. C. 2016. Update on the Pharmacology and Legal Status of Kratom. The Journal of the American Osteopathic Association 116 (12):802–09. doi:10.7556/jaoa.2016.156.
   PubMed Web of Science ®Google Scholar
• Sabetghadam, A., S. Ramanathan, S. Sasidharan, and S. M. Mansor. 2013. Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats. Journal of Ethnopharmacology 146:815–23. doi:10.1016/j.jep.2013.02.008.
   PubMed Web of Science ®Google Scholar
• Sahakian, B. J., and A M. Owen. 1992. Computerised assessment in neuropsychiatry using CANTAB: Discussion paper. Journal of the Royal Society of Medicine 85:399–402.
   PubMed Web of Science ®Google Scholar
• Science Letter on Kratom Feb 8th 2018. https://www.americankratom.org/science-letter-on-kratom.
   Google Scholar
• Senik, M. H., S. M. Mansor, G. Rammes, J. K. J. Tharakan, and J. Abdullah. 2012b. Mitragyna speciosa Korth standardized methanol extract induced short-term potentiation of CA1 subfield in rat hippocampal slices. Journal of Medicinal Plants Research 6 (7):1234–43. doi:10.5897/JMPR11.1283.
   Google Scholar
• Senik, M. H., S. M. Mansor, J. K. J. Tharakan, and J. M. B. Abdullah. 2012a. Effect of acute administration of Mitragyna speciosa Korth. Standardized methanol extract in animal model of learning and memory. Journal of Medicinal Plants Research 6 (6):1007–14.
   Google Scholar
• Singh, D., C. P. Muller, and B K. Vicknasingam. 2014. Kratom (mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139:132–137.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Muller, B. K. Vicknasingam, and S. M. Mansor. 2015. Social Functioning of Kratom (Mitragyna speciosa) Users in Malaysia. Journal of Psychoactive Drugs 47 (2):125–31. doi:10.1080/02791072.2015.1012610.
   PubMed Web of Science ®Google Scholar
• Singh, D., C. P. Muller, V. Murugaiyah, S. B. S. Hamid, B. K. Vicknasingam, B. Avery, N. J. Y. Chear, and S. M. Mansor. 2018. Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia. Journal of Ethnopharmacology 214:197–206. doi:10.1016/j.jep.2017.12.017.
   PubMed Web of Science ®Google Scholar
• Singh, D., S. Narayanan, and B. Vicknasingam. 2016. Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin 126:41–46. doi:10.1016/j.brainresbull.2016.05.004.
   PubMed Web of Science ®Google Scholar
• Smith, K. E., and T. Lawson. 2017. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependence 180:340–48. doi:10.1016/j.drugalcdep.2017.08.034.
   PubMed Web of Science ®Google Scholar
• Swogger, M. T., and Z. Walsh. 2018. Kratom use and mental health: A systematic review. Drug and Alcohol Dependence 183:134–40. doi:10.1016/j.drugalcdep.2017.10.012.
   PubMed Web of Science ®Google Scholar
• Tanguay, P. 2011. Kratom in Thailand: Decriminalisation and community control? Series on Legislative Reform of Drug Policies Nr. 13. Transnational Institute - International Drug Policy Consortium.
   Google Scholar
• Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21:283–88. doi:10.1016/j.drugpo.2009.12.003.
   PubMed Web of Science ®Google Scholar
• Yusoff, N. H. M., F. W. Suhaimi, R. K. Vadivelu, Z. Hassan, A. Rumler, A. Rotter, D. Amato, H. C. Dringenberg, S. M. Mansor, V. Navaratnam, et al. 2014. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addiction Biology 21:98–110. doi:10.1111/adb.12185.
   PubMed Web of Science ®Google Scholar
• Yusoff, N. H. M., S. M. Mansor, C. P. Muller, and Z. Hassan. 2017. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats. Behavioural Brain Research 332:1–6. doi:10.1016/j.bbr.2017.05.059.
   PubMed Web of Science ®Google Scholar